Clinical Trial Update: Pilot Study to Assess the Effect of High Dose N-acetylcysteine (NAC) in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 4]

View source ↗

Summary

Phase 4 pilot trial investigating high-dose N-acetylcysteine in COPD patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: COPD | Phase 4 | Status: COMPLETED